Right pricing to hold the key for Zydus Cadila's vaccine launch https://ift.tt/eA8V8J

Zydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. As Covaxin is set to become available for the same age group as well, the bargaining position of the government will improve, as negotiations are underway with Zydus regarding the price of the vaccine.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3mPXqgA